ASND (Ascendis Pharma AS) Beginning Cash Position: $712 Mil (As of Mar. 2026)


ASND Ascendis Pharma AS ASND
37 GF Score
Price $270.51
! 5 Warning Signs
View Full Analysis

What is Ascendis Pharma AS Beginning Cash Position?

Ascendis Pharma AS ASND -1.87% 37 Beginning Cash Position is $712 Mil as of Mar. 2026. GuruFocus rates ASND with a GF Score™ of 37/100. The stock has 5 warning signs investors should review.

Ascendis Pharma AS's Beginning Cash Position for the quarter that ended in Mar. 2026 was $712 Mil.

Ascendis Pharma AS's quarterly Beginning Cash Position increased from Sep. 2025 ($580 Mil) to Dec. 2025 ($631 Mil) and increased from Dec. 2025 ($631 Mil) to Mar. 2026 ($712 Mil).

Ascendis Pharma AS's annual Beginning Cash Position declined from Dec. 2023 ($485 Mil) to Dec. 2024 ($411 Mil) but then increased from Dec. 2024 ($411 Mil) to Dec. 2025 ($655 Mil).

Ascendis Pharma AS Beginning Cash Position Related Terms

Ascendis Pharma AS Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Ascendis Pharma AS's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma AS Beginning Cash Position Chart

Ascendis Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 660.47 472.74 485.03 410.64 655.20

Ascendis Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 604.91 597.37 579.87 631.26 712.19
ASND
37GF Score
Ascendis Pharma AS ASND
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Pharma AS Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $712 Mil mean?
Ascendis Pharma AS (ASND) has a Beginning Cash Position of $712 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Ascendis Pharma AS and its competitors.
Is Ascendis Pharma AS's Beginning Cash Position too high?
Ascendis Pharma AS's current Beginning Cash Position is $712 Mil. Overall, Ascendis Pharma AS has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Pharma AS's Beginning Cash Position compare to JAZZ and BBIO?
Ascendis Pharma AS's Beginning Cash Position of $712 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Ascendis Pharma AS and its competitors. Ascendis Pharma AS's current Beginning Cash Position is $712 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Pharma AS stock overvalued right now?
Ascendis Pharma AS (ASND) has a current Beginning Cash Position of $712 Mil. The current Beginning Cash Position is $712 Mil. Ascendis Pharma AS's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Ascendis Pharma AS (ASND), the current Beginning Cash Position is $712 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Pharma AS Business Description

Other Exchanges A1SN34:Brazil
Address Tuborg Boulevard 12, Hellerup, DNK, 2900
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
37GF Score

Get the complete analysis for ASND

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$270.51
Price